Experts Looked Inside Mylan's Upgraded EpiPen | NBC 6 South Florida
National & International News
The day’s top national and international news

Experts Looked Inside Mylan's Upgraded EpiPen

Both a curious doctor and a medical technology research firm say the new and older devices have a similar "core"



    James Cheng / for NBC News
    Dr. Julie C. Brown, a University of Washington School of Medicine pediatric emergency physician, holding two EpiPens, the new design at left and the old at right.

    With Congress trying to figure out Mylan's business model for the EpiPen, a medical technologies expert and a Seattle doctor have been physically taking apart the auto-injectors to find out exactly how the device has changed since Mylan acquired it, NBC News reported.

    Mylan CEO Heather Bresch testified last week that it invested more than $1 billion enhancing the product, which is one of the reason the Epipen's price has risen from $100 to $600.

    After a Seattle doctor cut open EpiPens from before and after Mylan's upgrades, NBC News sent versions of the epinephrine auto-injectors to a medical technology consulting firm. Despite seeing safety and graphics upgrades, both found the devices shared a similar "core."

    After NBC News sent the firm's results to Mylan, a spokesman for the drugmaker said it was "not familiar with the research referenced in your email" but contended that "anyone who has used the product knows, the epinephrine auto-injector we have in the market today is substantially different than the one we acquired."